Zobrazeno 1 - 10
of 134
pro vyhledávání: '"Russell, Kent"'
Autor:
Kyriakopoulos, Christos, Chen, Yu-Hui, Jeraj, Robert, Duan, Fenghai, Luo, Jun, Antonarakis, Emmanuel S., Tripathi, Abhishek, Kosoff, David, Garje, Rohan, Pachynski, Russell Kent, Parikh, Rahul Atul, Harzstark, Andrea, Adra, Nabil, Maughan, Benjamin L., Zakharia, Yousef, Corn, Paul Gettys, Liu, Glenn, Carducci, Michael Anthony
Publikováno v:
Journal of Clinical Oncology; 2024 Supplement 17, Vol. 42, pLBA5000-LBA5000, 83p
Autor:
Pachynski, Russell Kent, Chatta, Gurkamal S., Jain, Rohit K., Moon, Helen H., Sweis, Randy F., Delacroix, Scott Edward, Fang, Alana, D'amico, Leonard A., Kask, Angela Shaulov, Fling, Steven P., Lacroix, Andreanne, Kaiser, Judith C., Sharon, Elad, Yu, Evan Y.
Publikováno v:
Journal of Clinical Oncology; 2024 Supplement 4, Vol. 42, p628-628, 193p
Autor:
Pachynski, Russell Kent, Saeed, Muhammad Azeem, Peng, Bo, Van Tine, Brian Andrew, Sheikh, Nadeem Anwar, Fehniger, Todd A.
Publikováno v:
Journal of Clinical Oncology; 2024 Supplement 4, Vol. 42, p177-177, 235p
Autor:
Russell, Kent, Healy, Brian, Pantarotto, Jason, Laurie, Scott A., MacRae, Robert, Sabri, Elham, Wheatley-Price, Paul
Publikováno v:
In Clinical Lung Cancer May 2014 15(3):237-243
Autor:
RUSSELL, KENT
Publikováno v:
New Republic. 9/15/2014, Vol. 245 Issue 15, p18-29. 12p. 3 Color Photographs.
Autor:
Russell, Kent, Amir, Eitan, Paterson, Alexander, Josse, Robert, Addison, Christina, Kuchuk, Iryna, Clemons, Mark
Publikováno v:
In Journal of Bone Oncology December 2013 2(4):167-173
Publikováno v:
In Journal of Bone Oncology June 2012 1(1):12-17
Autor:
RUSSELL, KENT
Publikováno v:
New Republic. 9/16/2013, Vol. 244 Issue 15, p20-31. 12p. 5 Color Photographs, 1 Map.
Autor:
Russell, Kent
Publikováno v:
New Republic. 3/25/2013, Vol. 244 Issue 4, p28-35. 8p. 1 Color Photograph.
Autor:
Daniel P. Petrylak, Raffaele Ratta, Nobuaki Matsubara, Ernesto Pablo Korbenfeld, Rustem Gafanov, Loic Mourey, Tilman Todenhöfer, Howard Gurney, Gero Kramer, Andre M. Bergman, Pawel Zalewski, Maria De Santis, Andrew J. Armstrong, Winald R. Gerritsen, Russell Kent Pachynski, Todd L. Saretsky, Sameer R. Ghate, Xin Tong Li, Charles Schloss, Karim Fizazi
Publikováno v:
Journal of Clinical Oncology. 41:129-129
129 Background: The double-blind, phase 3, randomized KEYNOTE-921 trial (NCT03834506) showed that pembro + docetaxel did not significantly improve rPFS or OS for pts with mCRPC treated with prior next-generation hormonal agent (NHA) therapy. We prese